Cargando…

Naturally occurring spike mutations influence the infectivity and immunogenicity of SARS-CoV-2

Mutations in SARS-CoV-2 variants of concern (VOCs) have enhanced transmissibility and immune evasion with respect to current vaccines and neutralizing antibodies (NAbs). How naturally occurring spike mutations affect the infectivity and antigenicity of VOCs remains to be investigated. The entry effi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Peng, Qiaoli, Zhou, Runhong, Liu, Na, Wang, Hui, Xu, Haoran, Zhao, Meiqing, Yang, Dawei, Au, Ka-Kit, Huang, Haode, Liu, Li, Chen, Zhiwei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9554397/ https://www.ncbi.nlm.nih.gov/pubmed/36224497 http://dx.doi.org/10.1038/s41423-022-00924-8

Ejemplares similares

Waning immune responses against SARS-CoV-2 variants of concern among vaccinees in Hong Kong
por: Peng, Qiaoli, et al.
Publicado: (2022)

Vaccine‐breakthrough infection by the SARS‐CoV‐2 omicron variant elicits broadly cross‐reactive immune responses
por: Zhou, Runhong, et al.
Publicado: (2022)

Three-dose vaccination-induced immune responses protect against SARS-CoV-2 Omicron BA.2: a population-based study in Hong Kong
por: Zhou, Runhong, et al.
Publicado: (2022)

Nasal prevention of SARS-CoV-2 infection by intranasal influenza-based boost vaccination in mouse models
por: Zhou, Runhong, et al.
Publicado: (2021)

Antibody signature induced by SARS-CoV-2 spike protein immunogens in rabbits
por: Ravichandran, Supriya, et al.
Publicado: (2020)

Characterization and immunogenicity of SARS-CoV-2 spike proteins with varied glycosylation
por: Deng, Tingting, et al.
Publicado: (2022)

Structural insights into broadly neutralizing antibodies elicited by hybrid immunity against SARS-CoV-2
por: Luo, Mengxiao, et al.
Publicado: (2023)

Human neutralizing antibodies for SARS-CoV-2 prevention and immunotherapy
por: Zhou, Dongyan, et al.
Publicado: (2021)

Effect of natural mutations of SARS-CoV-2 on spike structure, conformation, and antigenicity
por: Gobeil, Sophie M.-C., et al.
Publicado: (2021)

Characterization of an attenuated SARS-CoV-2 variant with a deletion at the S1/S2 junction of the spike protein
por: Wang, Pui, et al.
Publicado: (2021)

Design of a highly thermotolerant, immunogenic SARS-CoV-2 spike fragment
por: Malladi, Sameer Kumar, et al.
Publicado: (2020)

Immunogenicity of candidate SARS-CoV-2 DNA vaccines based on the spike protein
por: Lim, Heeji, et al.
Publicado: (2022)

SARS-CoV-2 S2P spike ages through distinct states with altered immunogenicity
por: Olia, Adam S., et al.
Publicado: (2021)

SARS-CoV-2 hijacks neutralizing dimeric IgA for nasal infection and injury in Syrian hamsters(1)
por: Zhou, Biao, et al.
Publicado: (2023)

Naturally occurring mutations of SARS-CoV-2 main protease confer drug resistance to nirmatrelvir
por: Hu, Yanmei, et al.
Publicado: (2022)

Naturally Occurring Mutations of SARS-CoV-2 Main Protease Confer Drug Resistance to Nirmatrelvir
por: Hu, Yanmei, et al.
Publicado: (2023)

The SARS-CoV-2 Spike Glycoprotein Biosynthesis, Structure, Function, and Antigenicity: Implications for the Design of Spike-Based Vaccine Immunogens
por: Duan, Liangwei, et al.
Publicado: (2020)

SARS-CoV-2 Spike Protein-Expressing Enterococcus for Oral Vaccination: Immunogenicity and Protection
por: Suvorov, Alexander, et al.
Publicado: (2023)

Exploring the efficacy of naturally occurring biflavone based antioxidants towards the inhibition of the SARS-CoV-2 spike glycoprotein mediated membrane fusion
por: Mondal, Samiran, et al.
Publicado: (2021)

Immunogenicity of the spike glycoprotein of Bat SARS-like coronavirus
por: Hou, Yu-xuan, et al.
Publicado: (2010)

A broadly neutralizing antibody protects Syrian hamsters against SARS-CoV-2 Omicron challenge
por: Zhou, Biao, et al.
Publicado: (2022)

SARS-CoV-2 RNA Detection with Duplex-Specific Nuclease Signal Amplification
por: Liu, Meiqing, et al.
Publicado: (2021)

Acute SARS-CoV-2 Infection Impairs Dendritic Cell and T Cell Responses
por: Zhou, Runhong, et al.
Publicado: (2020)

Analyzing Effects of Naturally Occurring Missense Mutations
por: Zhang, Zhe, et al.
Publicado: (2012)

Naturally occurring SARS-CoV-2 gene deletions close to the spike S1/S2 cleavage site in the viral quasispecies of COVID19 patients
por: Andrés, Cristina, et al.
Publicado: (2020)

Rational Design of SARS-CoV-2 Spike Glycoproteins To Increase Immunogenicity By T Cell Epitope Engineering
por: Ong, Edison, et al.
Publicado: (2020)

Computational design of SARS-CoV-2 spike glycoproteins to increase immunogenicity by T cell epitope engineering
por: Ong, Edison, et al.
Publicado: (2020)

Rationally designed immunogens enable immune focusing following SARS-CoV-2 spike imprinting
por: Hauser, Blake M., et al.
Publicado: (2022)

Immunogenicity of the Xcl1-SARS-CoV-2 Spike Fusion DNA Vaccine for COVID-19
por: Qi, Hailong, et al.
Publicado: (2022)

Immunogenicity of SARS-CoV-2 spike antigens derived from Beta & Delta variants of concern
por: Akache, Bassel, et al.
Publicado: (2022)

Stabilized recombinant SARS-CoV-2 spike antigen enhances vaccine immunogenicity and protective capacity
por: Meyer zu Natrup, Christian, et al.
Publicado: (2022)

Structural and computational design of a SARS-CoV-2 spike antigen with improved expression and immunogenicity
por: Williams, James A., et al.
Publicado: (2023)

Immunogenicity of Candidate MERS-CoV DNA Vaccines Based on the Spike Protein
por: Al-amri, Sawsan S., et al.
Publicado: (2017)

The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity
por: Li, Qianqian, et al.
Publicado: (2020)

Introduction and effect of natural selection analysis at common mutations of SARS-CoV-2 spike gene in Iran
por: Nedaei, Fatemeh, et al.
Publicado: (2023)

The effect of spike mutations on SARS-CoV-2 neutralization
por: Rees-Spear, Chloe, et al.
Publicado: (2021)

Mutations and Evolution of the SARS-CoV-2 Spike Protein
por: Magazine, Nicholas, et al.
Publicado: (2022)

Identification of immunogenic determinants of the spike protein of SARS-like coronavirus
por: Zhou, Peng, et al.
Publicado: (2013)

35B5 antibody potently neutralizes SARS-CoV-2 Omicron by disrupting the N-glycan switch via a conserved spike epitope
por: Wang, Xiaofei, et al.
Publicado: (2022)

SARS-CoV-2 spike glycoprotein vaccine candidate NVX-CoV2373 immunogenicity in baboons and protection in mice
por: Tian, Jing-Hui, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qhmqiaiu4rsqhfb0q1f0cmhh5v